The Europe veterinary vaccines market growth is projected to progress at a CAGR of 6.97% during the forecast period, 2022-2030, and is set to reach a revenue share of $3954.24 million by 2030.

EUROPE VETERINARY VACCINES MARKET FORECAST 2022-2030

Europe Veterinary Vaccines Market by Animal Type (Livestock Animal, Companion Animal, Aquaculture) Market by Product Type (Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vaccines, Subunit Vaccines) Market by Disease Type (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Diseases) by Geography

Request free sample

The Europe veterinary vaccines market growth is projected to progress at a CAGR of 6.97% during the forecast period, 2022-2030, and is set to reach a revenue share of $3954.24 million by 2030.

The region has the presence of several international veterinary pharmaceutical players that have bases and origins in various European countries. This facilitates foreign investments that impact the overall market growth. Also, advancements in vaccines, innovations, R&D, and technology enable market growth in the region.

Europe Veterinary Vaccines Market

To know more about this report, request a free sample copy

The Europe veterinary vaccines market growth assessment includes the evaluation of the United Kingdom, Poland, Belgium, Russia, Italy, France, Germany, and Rest of Europe.In the United Kingdom, the presence of the Veterinary Medicines Directorate (VMD) is an executive agency that has the power to authorize veterinary medicines and monitor their efficacy and safety post-authorization. Also, the Animal Welfare Committee (AWC) is another committee that advises and assists the government on different animal health-related problems.

In addition, as of December 2020, the UK has around 21.8 million lambs and sheep, 4.8 million pigs, and 9.4 million cattle animals, according to government data. This increases the vulnerability to livestock disease types like Johne’s disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD), and bluetongue. Moreover, the UK is home to almost 900 thousand rabbits, 10.7 million cats, and 9.6 million dogs making it a conducive market for pet products and pet care. At the same time, companion animals are at the risk of disease contraction, and therefore, there is a growing need for vaccinations.

In Germany, according to the Federal Ministry of Food and Agriculture (BMEL), the country has a cattle population of around 11.4 million. Also, as per the same Ministry, Germany is the second-largest producer of veal and beef and the largest milk producer in the EU. Additionally, the swine population stands at almost 25.5 million, making it the third-biggest producer of pork globally and the biggest producer in Europe. Consequently, veterinarians and farm animal producers are looking to sustain these numbers through livestock health maintenance. Also, the country has the presence of many major market players.

The report scope of the Europe veterinary vaccines market includes the segmentation analysis of disease type, animal type, and product type. The animal type is further categorized into livestock animal, aquaculture, and companion animal. The companion animal segment is further sub-segmented into canine, feline, and equine. Feline animals include tigers, lions, cats, etc. Cats are the most vastly domesticated feline animals. Felines are at risk of diseases like heartworm, feline leukemia virus (FelV), and feline immunodeficiency virus (FIV). The vaccines available in the market for such diseases include Fel-O-Vax® by Elanco, Nobivac® by MSD Animal Health, FELIGEN® CRP by Virbac, etc.

Equine animals include zebras and horses. Horses are the most domesticated animals for sports, leisure, and farm use purposes. However, currently, they are considered animals that require high care and maintenance. These animals are vulnerable to Equine Infectious Anemia Virus, Cryptosporidiosis, and Eastern Equine Encephalitis.

Some of the important players include Vaxxinova GmbH, Virbac SA, Zoetis, Phibro Animal Health, etc.

Zoetis is an animal health company that develops, manufactures, and commercializes diagnostic products, vaccines, and medicines. It serves livestock producers, veterinarians, and people who raise companion & farm animals. The company operates in the United Kingdom, China, Brazil, Australia, and the United States, with headquarters in New Jersey.

One of its main products, Fellocell 3, is a non-adjuvanted modified-live virus (MLV) vaccine. It helps prevent FVR (feline viral rhinotracheitis) caused by feline herpesvirus-1, feline panleukopenia (FPL) caused by FPV (feline parvovirus), and respiratory disease caused by FCV (feline calicivirus).

Report Synopsis

Report ScopeDetails
Market Forecast Years2022-2030
Base Year2021
Market Historical Years2018-2021
Forecast UnitsRevenue (Million)
Segments AnalyzedProduct Type, Animal Type, Disease Type
Countries AnalyzedThe United Kingdom, Poland, Belgium, Russia, Italy, France, Germany, and Rest of Europe
Companies Analyzed

Boehringer Ingelheim International GmbH, Brilliant Bio Pharma, Ceva Sante Animale, Elanco Animal Health, Hester Biosciences Ltd, Hipra, Indian Immunologicals Limited, Merck Animal Health, Phibro Animal Health, Vaxxinova GmbH, Virbac SA, and Zoetis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RESEARCH & DEVELOPMENT OF ADVANCED VACCINES
        • NEED OF VACCINE DUE TO RISING ANIMAL POPULATION AND DISEASES
        • VACCINATION DRIVES BY GOVERNMENT AGENCIES
      • KEY RESTRAINTS
        • RULES & REGULATIONS FOR THE USE OF VACCINE
        • LACK OF AWARENESS AMONG FARMERS AND REQUIREMENT OF SKILLED VETERINARIANS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
      • REGULATORY FRAMEWORK
    2. MARKET BY ANIMAL TYPE
      • LIVESTOCK ANIMAL
        • CATTLE
        • PIGS
        • POULTRY
        • SHEEP
        • OTHER LIVESTOCK ANIMALS
      • COMPANION ANIMAL
        • CANINE
        • FELINE
        • EQUINE
      • AQUACULTURE
    3. MARKET BY PRODUCT TYPE
      • ATTENUATED VACCINES
      • INACTIVATED VACCINES
      • TOXOID VACCINES
      • CONJUGATE VACCINES
      • DNA VACCINES
      • RECOMBINANT VACCINES
      • SUBUNIT VACCINES
    4. MARKET BY DISEASE TYPE
      • CANINE DISEASE
      • PORCINE DISEASE
      • BOVINE DISEASE
      • POULTRY DISEASE
      • AQUACULTURE DISEASE
      • OTHER DISEASES
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
        • BRILLIANT BIO PHARMA
        • CEVA SANTE ANIMALE
        • ELANCO ANIMAL HEALTH
        • HESTER BIOSCIENCES LTD
        • HIPRA
        • INDIAN IMMUNOLOGICALS LIMITED
        • MERCK ANIMAL HEALTH
        • PHIBRO ANIMAL HEALTH
        • VAXXINOVA GMBH
        • VIRBAC SA
        • ZOETIS

    LIST OF TABLES

    TABLE 1:  MARKET SNAPSHOT – VETERINARY VACCINES

    TABLE 2:  REGULATORY FRAMEWORK

    TABLE 3:  EUROPE VETERINARY VACCINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 4:  EUROPE VETERINARY VACCINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 5:  EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6:  EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 7:  EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8:  EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 9:  EUROPE VETERINARY VACCINES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10:  EUROPE VETERINARY VACCINES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 11:  EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 12:  EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 13:  EUROPE VETERINARY VACCINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 14:  EUROPE VETERINARY VACCINES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 15:  LEADING PLAYERS OPERATING IN EUROPE VETERINARY VACCINES MARKET

    TABLE 16:  LIST OF MERGERS & ACQUISITIONS

    TABLE 17:  LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 18:  LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 19:  LIST OF BUSINESS EXPANSIONS & DIVESTITURES                                 

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: VALUE CHAIN ANALYSIS

    FIGURE 4: KEY BUYING CRITERIA

    FIGURE 5: EUROPE VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY ANIMAL TYPE, IN 2021

    FIGURE 6: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, 2022-2030 (IN $ MILLION)

    FIGURE 7: EUROPE VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY LIVESTOCK ANIMAL, IN 2021

    FIGURE 8: EUROPE VETERINARY VACCINES MARKET, BY CATTLE, 2022-2030 (IN $ MILLION)

    FIGURE 9: EUROPE VETERINARY VACCINES MARKET, BY PIGS, 2022-2030 (IN $ MILLION)

    FIGURE 10: EUROPE VETERINARY VACCINES MARKET, BY POULTRY, 2022-2030 (IN $ MILLION)

    FIGURE 11: EUROPE VETERINARY VACCINES MARKET, BY SHEEP, 2022-2030 (IN $ MILLION)

    FIGURE 12: EUROPE VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2030 (IN $ MILLION)

    FIGURE 13: EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMAL, 2022-2030 (IN $ MILLION)

    FIGURE 14: EUROPE VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY COMPANION ANIMAL TYPE, IN 2021

    FIGURE 15: EUROPE VETERINARY VACCINES MARKET, BY CANINE, 2022-2030 (IN $ MILLION)

    FIGURE 16: EUROPE VETERINARY VACCINES MARKET, BY FELINE, 2022-2030 (IN $ MILLION)

    FIGURE 17: EUROPE VETERINARY VACCINES MARKET, BY EQUINE, 2022-2030 (IN $ MILLION)

    FIGURE 18: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2030 (IN $ MILLION)

    FIGURE 19: EUROPE VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

    FIGURE 20: EUROPE VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 21: EUROPE VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 22: EUROPE VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 23: EUROPE VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 24: EUROPE VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 25: EUROPE VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 26: EUROPE VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2030 (IN $ MILLION)

    FIGURE 27: EUROPE VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY DISEASE TYPE, IN 2021

    FIGURE 28: EUROPE VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 29: EUROPE VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 30: EUROPE VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 31: EUROPE VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 32: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 33: EUROPE VETERINARY VACCINES MARKET, BY OTHER DISEASES, 2022-2030 (IN $ MILLION)

    FIGURE 34: EUROPE VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 35: UNITED KINGDOM VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 36: GERMANY VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 37: FRANCE VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 38: ITALY VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 39: RUSSIA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 40: BELGIUM VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 41: POLAND VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 42: REST OF EUROPE VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY ANIMAL TYPE
      • LIVESTOCK ANIMAL
        • CATTLE
        • PIGS
        • POULTRY
        • SHEEP
        • OTHER LIVESTOCK ANIMALS
      • COMPANION ANIMAL
        • CANINE
        • FELINE
        • EQUINE
      • AQUACULTURE
    2. MARKET BY PRODUCT TYPE
      • ATTENUATED VACCINES
      • INACTIVATED VACCINES
      • TOXOID VACCINES
      • CONJUGATE VACCINES
      • DNA VACCINES
      • RECOMBINANT VACCINES
      • SUBUNIT VACCINES
    3. MARKET BY DISEASE TYPE
      • CANINE DISEASE
      • PORCINE DISEASE
      • BOVINE DISEASE
      • POULTRY DISEASE
      • AQUACULTURE DISEASE
      • OTHER DISEASES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type